Stock of the Day
December 29, 2023
Madrigal Pharmaceuticals (MDGL)
$280.69
+$6.59 (+2.4%)
Market Cap:
$6.23B
About Madrigal Pharmaceuticals
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH.
The company is headquartered in West Conshohocken, Pennsylvania.
← Previous Stock of the Day
Next Stock of the Day →
Recent News
Madrigal Pharmaceuticals to Present at 46th Annual Goldman Sachs Health Care Conference
(msn.com)
Madrigal Pharmaceuticals to Participate in the 46th Annual Global Goldman Sachs Health Care Conference
(globenewswire.com)